Dashboard
LoginSign Up

Financial News

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
manilatimes40d ago

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its base of subscription contracts, adding multi-year agreements that represent millions of dollars in incremental recurring revenue.The agreement was executed in record time following the companies’ initial meeting, reflecting strong commercial alignment, clear product-market fit, and immediate value to the customer. Data delivery is now underway and will be continuously delivered over a three-month project under a licensing agreement, delivering diverse multimodal data at scale. The speed of execution underscores the value Risorius placed on OneMedNet’s regulatory-grade data assets and delivery model.Under the agreement, Risorius has licensed access to large-scale electroencephalography (EEG) and polysomnography (PSG) waveform data paired with clinically meaningful context and longitudinal follow-up. The datasets will support internal R&D, model development, and validation efforts, including the advancement of EEG-based digital biomarkers and an AI Co-Scientist platform designed to support neurological and psychiatric clinical studies, especially for pharmaceutical companies and academic hospitals.Risorius selected OneMedNet based on the strong fit for its R&D requirements. Key differentiators included access to Multi-modal data including high-fidelity EEG and PSG waveforms paired with longitudinal clinical data, substantial data volume to support potential program expansion, a transparent and structured curation process, and a well-organized de-identification workflow. The practical subscription licensing approach enabled Risorius to move quickly from evaluation to execution.Aaron Green, CEO and President of OneMedNet, stated: "Risorius’ rapid decision to partner with OneMedNet underscores the value of our regulatory-grade neuro data and continuous delivery model. Real-World EEG and PSG waveform data, when paired with longitudinal clinical results, are foundational to the research and development of next-generation solutions focused on solving central nervous system disorders. This agreement reflects growing demand from AI-native companies seeking scalable, high-quality datasets to power digital biomarker development and advanced analytics.”Sangyoon Bae, CEO of Risorius, added, "We chose OneMedNet because of the clear alignment with our scientific and operational needs. The combination of well-curated EEG and PSG waveform data, meaningful longitudinal follow-up, and a scalable licensing model provides the foundation we need to accelerate internal R&D, model validation, and development of our AI Co-Scientist platform. As we are speeding up on our database construction and R&D projects, we anticipate that this partnership will contribute to our technological competiveness.”The partnership highlights continued momentum in OneMedNet’s data licensing strategy, our breadth and depth of available data and sales expansion within the high-growth neuro and CNS vertical. The efficient commercial execution demonstrated by rapid contract conversion indicates OneMedNet is positioned as a trusted infrastructure partner enabling AI innovation.About OneMedNet CorporationOneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 2,130 healthcare sites through its iRWDTM platform. This isn’t just data-it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities-rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.About RisoriusRisorius is a neurotechnology AI company, with the vision of innovation and optimization of the psychiatric and neurologic field. By building EEG-based digital biomarkers and AI-powered research platforms to advance central nervous system innovation across neurology, psychiatry, and sleep, Risorius develops scalable pipelines for signal processing, quality control, and multimodal analytics. This enables biomarker discovery, treatment response modeling, and evidence generation from real-world clinical data.Risorius is also developing an AI Co-Scientist platform that helps research teams optimize analysis workflows regarding CNS and accelerate hypothesis testing and clinical studies. By translating EEG signal data into actionable insights, Risorius aims to support faster, more data-driven decision-making for CNS research and care delivery.Learn more at www.risorius.krCautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding our products, plans and strategies, and our ability to achieve our operational strategies.Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include, but are not limited to: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Digital Assets, including Digital Asset’s volatility; our ability to implement our Digital Asset treasury strategy and its effects on our business; and the other risks described in our most recent Annual Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.OneMedNet Contacts:Michael Wong, VP MarketingEmail: michael.wong@onemednet.comRisorius Contacts:YongKeun Song, COOEmail: yksong16@risorius.krSOURCE: ONEMEDNET CORPORATION

#TECH
Transcript: Hilary Allen on Fintech Dystopia
ritholtz40d ago

Transcript: Hilary Allen on Fintech Dystopia

The transcript from this week’s, MiB: Hilary Allen on Fintech Dystopia, is below. You can stream and download our full conversation, including any podcast extras, on Apple Podcasts, Spotify, YouTube (video), YouTube (audio), and Bloomberg. All of our earlier podcasts on your favorite pod hosts can be found here. ~~~ [00:00:02] Announcer: This is...Read More The post Transcript: Hilary Allen on Fintech Dystopia appeared first on The Big Picture.

#ECONOMY
Abhyudaya – Industry Leadership Conclave 2026: Charting the roadmap
organiser40d ago

Abhyudaya – Industry Leadership Conclave 2026: Charting the roadmap

This year’s Budget is extremely significant. With the goal of Viksit Bharat by 2047, it must be seen as a foundational vision document. Across the country, outreach programmes are being conducted, and all suggestions received will be incorporated. We are engaging at the state level as well,” stated Gopal Krishna Agarwal, National Chairperson of the Bharatiya Janata Party Economic Affairs Cell and National Spokesperson of BJP. He was speaking at the MSME Round Table that was convened as part of the ‘Abhyudaya’ event in Bhopal, bringing together policymakers, entrepreneurs and domain experts for a focused and policy-oriented discussion. The conference was chaired by Gopal Krishna Agarwal. In his opening remarks, Agarwal noted that across 11 consecutive Budgets, Bharat has maintained strong macroeconomic fundamentals. High growth rates have been sustained, inflation has been kept under control, and the debt to GDP ratio has been managed prudently. From cooperative to competitive federalism On the strength of these fundamentals, the Government is now preparing to accelerate growth further. Agarwal observed that while cooperative federalism has been a defining feature of recent years, the current Budget introduces a new dimension, competitive federalism. In the past, projects were directly assigned to specific states. However, this time, many schemes have been left open-ended. States are expected to bring forward their own proposals to the Central Government and projects will be sanctioned based on merit rather than pre-allocation. Six key focus areas have been identified under this approach – Mega Textile Parks, Revival of 200 MSME Legacy Clusters, Development of Iconic Heritage Sites, City Economic Zones with Rs 5,000 crore infrastructure support, Health Services Hubs, and Entrepreneurship Development Hubs. A massive Rs 12.2 lakh crore has been allocated for infrastructure. In addition, states have been provided access to Rs 5 lakh crore through 50-year interest-free bonds to accelerate development. The conference also discussed future-oriented sunrise sectors that are expected to drive long-term growth. These include global data centres, space technology, nuclear power, power sector expansion, rare earth metals, high-tech tools, AI support systems and the cultural economy. These sectors are expected to benefit MSMEs directly, particularly within the framework of Free Trade Agreements (FTAs). Just as the Goods and Services Tax (GST) underwent structural reforms, significant changes are anticipated in customs duty structures. Discussions are underway to drastically reduce duties on technology imports, and the government is actively working in this direction. Licensing Reform And Ease Of Doing Business Several speakers highlighted the need for systemic reforms in licensing and compliance. Dr RS Goswami, CMD, Hind Pharma pointed out that under the Factory Act, permits and licenses have been extended to a 10-year validity period without annual renewal to enhance ease of doing business. He observed that 99 per cent of industries manufacture simple and unregulated products. Once the prescribed fee is deposited, a 10-year validity is granted. Yet exploitation persists. In the event of accidents or fire incidents, authorities often question the validity of licenses. MSME Definition, Incentives And Manufacturing Excellence At the state level, the investment limit under MSME definitions has been increased. However, if investment exceeds Rs 10 crore, proposals must go before a state-level committee, and incentives are disbursed over seven years. At the district level, incentives are provided over five years. It was suggested that incentives for manufacturing excellence should be limited to five years to encourage efficiency. For export-oriented units, selecting 5,000 industries across sectors could prepare Bharat for global competition. ­­Speakers cautioned that once FTAs are operational and imports increase significantly, domestic industries must be prepared to compete effectively. Although MSME is technically a state subject, the MSME Act of 2006 was passed by the Government of India. Uniform nationwide implementation remains incomplete, and reforms may be necessary to ensure consistency. Startups, Finance And Manufacturing Focus Participants observed that while startups are emerging rapidly, many are also failing. Technology alone is insufficient; integration with finance and economic viability is essential. Bharat’s comparative advantage has traditionally been in the service sector, but the long-term growth opportunity lies in manufacturing. Credit policy must be straightforward and affordable. With borrowing costs ranging between 15 and 16 per cent, industries struggle to survive. Procurement policy reforms were also discussed. MSME preference should be embedded in modern legislative frameworks. Each state should incorporate domestic preference in procurement policies. Concerns were raised about procurement practices in sectors like railways, where goods and works procurement operate under different frameworks. In the works segment, participation appears concentrated, limiting broader domestic involvement. Integrating Traditional And Emerging Sectors Dr Sandhya Chouksey, Executive Director, LNCT Group Bhopal, shared innovative integration models. A large gaushala spanning 25 hectares with a 12,000 cattle capacity is being developed through the municipal corporation. The discussion examined how mechanical students and MSMEs could collaborate in cow-based agriculture and related industries. There was also interest in developing the Narmada Path as an eco-tourism model, linking traditional assets with modern enterprise frameworks. Sumit Pandey, MD, FALCON India, highlighted interstate investment barriers. For example, if an investor from Maharashtra wishes to invest in Madhya Pradesh, procedural hurdles often arise. A national-level integrated software solution could resolve this. He cited the success of the 181 helpline in grievance redressal and suggested establishing a similar industrial helpline to address compliance-related issues. Strengthening the Udyog Mitra model was also proposed. The rapid embedding of generative AI into global systems was discussed extensively by Siddhartha Rastogi, Principal Officer, MD and Chief Operating Officer AMBIT Asset Management. However, Bharat currently lacks a clear policy framework for global data warehouses, electricity infrastructure and hardware integration. A single-window clearance mechanism in these sectors would be beneficial. Karan Khurana, Managing Director of Sage Group, emphasised that to utilise FTAs effectively, beginner-level support must be provided to MSMEs and startups. Approval timelines require reduction, and tracking mechanisms must be established. Bharat needs more R&D hubs and innovation laboratories. For FTA enablement, digital certification, mutual recognition agreements and proactive import-export clearance support are necessary. Strengthening standards and quality certifications is critical. Government involvement in discovery and sales enablement was [...]

#ECONOMY
Sovos and Label Announce Partnership to Deliver Comprehensive CARF Reporting Solutions for Digital Asset Platforms
businesswire40d ago

Sovos and Label Announce Partnership to Deliver Comprehensive CARF Reporting Solutions for Digital Asset Platforms

ATLANTA--(BUSINESS WIRE)--Sovos, the always-on tax compliance company, today announced that Label, a specialized provider of automated FATCA, CRS, and CARF compliance solutions, has joined the Sovos Partner Network. Label CARF + Sovos 1099-DA delivers a global solution for digital asset platforms to meet the OECD's Crypto-Asset Reporting Framework (CARF) requirements, which mandate comprehensive reporting of crypto transactions beginning in 2027 for the 2026 tax year in participating jurisdicti

#CRYPTO